Tvardi Therapeutics (TVRD) Cash from Financing Activities (2013 - 2025)
Tvardi Therapeutics (TVRD) posted Cash from Financing Activities of $1,000 for Q4 2025, down 100.0% from $27.01 million a year earlier.
Tvardi Therapeutics (TVRD) Cash from Financing Activities (2013 - 2025) Analysis & Trends
For FY2025, Tvardi Therapeutics' Cash from Financing Activities came in at $22.7 million, down 15.9% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of -10.3% (FY2020 to FY2025).
- In prior years, Tvardi Therapeutics' Cash from Financing Activities was $27 million in FY2024 (-29.2%), $38.15 million in FY2023, $311,000 in FY2022 (-99.3%) and $46.61 million in FY2021 (+19.1%).
- Quarterly Cash from Financing Activities has run from a low of -$1.6 million in Q1 2025 to a high of $45.29 million in Q4 2021 over five years.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q3 2023, with growth of 973.1%; the weakest was Q4 2025, with a decline of 100.0%.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was -$322,000 (Q3 2025), $24.63 million (Q2 2025) and -$1.6 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Tvardi Therapeutics | 11.73 Mn | 11.73 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -322,000.00 |
| Jun 30, 2025 | 24.63 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | 27.01 Mn |
| Sep 30, 2024 | -14,000.00 |
| Jun 30, 2024 | 690,000.00 |
| Mar 31, 2024 | -685,000.00 |
| Dec 31, 2023 | 36.48 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 560,000.00 |
| Dec 31, 2022 | 22,000.00 |
| Sep 30, 2022 | 104,000.00 |
| Jun 30, 2022 | 182,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 45.29 Mn |
| Sep 30, 2021 | 339,000.00 |
| Jun 30, 2021 | 293,000.00 |
| Mar 31, 2021 | 688,000.00 |
| Dec 31, 2020 | 38.47 Mn |
Tvardi Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TVRD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();